Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.459 SEK | -5.36% | +1.09% | -11.19% |
04-16 | Mendus AB Announces Board Changes | CI |
03-27 | Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML | CI |
- Stock Market
- Equities
- IMMU Stock
- News Mendus AB
- MarketScreener Editorial Features